Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analysis of ligand-macromolecule contacts: computational methods.

Nagarajan Pattabiraman1

  • 1Advanced Biomedical Computing Center, SAIC, NCI-Frederick, P. O. Box B, Frederick, MD 21702-1201, USA. Nagarajan.Pattabiraman@astrazeneca.com

Current Medicinal Chemistry
|April 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in Lymphoma.

Cancers·2025
Same author

Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. <i>Cancers</i> 2020, <i>12</i>, 3412.

Cancers·2025
Same author

Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.

Cancers·2020
Same author

GlyGen data model and processing workflow.

Bioinformatics (Oxford, England)·2020
Same author

GlyGen: Computational and Informatics Resources for Glycoscience.

Glycobiology·2019
Same author

Dysregulated calcium homeostasis prevents plasma membrane repair in Anoctamin 5/TMEM16E-deficient patient muscle cells.

Cell death discovery·2019

Computational methods now quantify ligand-macromolecule interactions, aiding drug design and protein engineering. This advances structure-based drug design by integrating diverse biological data for better target identification and ligand development.

Area of Science:

  • Biotechnology and Bioinformatics
  • Molecular Biology
  • Computational Chemistry

Background:

  • Biology is rapidly advancing due to technological progress, leading to increased identification of disease-related biomolecular targets.
  • Structure-based drug design integrates clinical, cellular, biochemical, structural, and biophysical data.
  • Advances in genomics, chemical synthesis, structure determination (X-ray, NMR), and computing fuel structure-based drug design.

Purpose of the Study:

  • To review computational methods for evaluating ligand-macromolecule contacts.
  • To highlight methods that quantify the nature and strength of these interactions.
  • To demonstrate the utility of these methods for medicinal chemists and molecular biologists.

Main Methods:

  • Focus on computational approaches for analyzing ligand-macromolecule interactions.

Related Experiment Videos

  • Utilizing computer-based visualization and quantification techniques.
  • Reviewing methods developed since 1990 for evaluating ligand binding.

    • Main Results:

    • Computational methods can visualize and quantify ligand-macromolecule contacts.
    • Quantification provides insights into the nature and strength of binding interactions.
    • These quantitative data are valuable for designing new ligands and proteins.

    Conclusions:

    • Computational methods are crucial for advancing structure-based drug design.
    • Quantifying ligand-macromolecule contacts enhances rational drug discovery and protein engineering.
    • Interdisciplinary understanding of computational and experimental techniques is essential.